Europe’s Drugmakers May Boost Acquisitions After Buybacks

Europe’s Drugmakers May Boost Acquisitions After Buybacks

Norm Betts/Bloomberg

The drug-making industry faces the possible loss of $21 billion in sales this year from patent expirations, so the incentive to acquire companies to gain new products will grow.